CompuGROUP stalls offer for iSoft:
This article was originally published in Clinica
CompuGROUP (Koblenz, Germany) has announced it will not increase its offer for iSoft, a move which leaves Australian firm IBA Health as the frontrunner to buy the UK medical software supplier. IBA's offer of 69p per share trumped CompuGROUP's bid of 66p per share (see Clinica No 1270, p 13).
You may also be interested in...
Yuyao YiJia Daily Chemical told FDA placed all drugs it manufactures on import alert in September because its methods and controls for manufacturing OTC sanitizers and other products do not appear to conform to current drug GMPs.
One of the first US telemed bills out of the gate in 2021 calls for permanently ending limits on CMS telehealth payments.
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.